ReviewExploration of targeted anti-tumor therapy2024

The promises and perils of circulating tumor DNA for monitoring immunotherapy response in non-small cell lung cancer.

Brandon Joseph Hebert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.